Geojit BNP Paribas Broker Research reports

*over or under performance to benchmark index Dr. Reddy's Laboratories (Dr. Reddy's) is an Indian pharmaceuticals company that manufactures and markets more than 190 medications, 180+ active pharmaceutical...

with multiple regulatory milestones lined up in the coming quarters. Execution of the pipeline delivery and expansion initiatives is expected to support long-term value creation. Therefore, we maintain our rating on the stock at BUY, with rolledforward target price of Rs. 1,348, based on 17.5x FY27x Adj. EPS....

FY25 PAT stood at 3,059 Cr, but adjusted PAT stood at 2,422cr.(+27.7%) due to a one-time, non-cash deferred tax liability reversal of 637cr., following a shift to the new tax regime and reassessment of MAT credit utilisation....

Narayana continues to deliver stable performance, driven by improved throughput rather than bed expansion. While the Indian business remained steady in FY25, the Cayman segment outperformed with 50% YoY sales growth and margin gains in Q4FY25. In our...

of non-core assets will control debt, and deleveraging from cash accrual is expected in FY27. We value TRCL at 15x FY27E EV/EBITDA (3Yr avg=~14x) to arrive at a target price of Rs. 1,268, and upgrade to Buy rating....

The company's revenue grew in double digits. However, its margin and profitability declined due to higher cost of sales. Nevertheless, the management is optimistic about near-term prospects of the natural gas transmission business, driven by an expected transmission tariff hike and volume growth. It anticipates a revision in transmission tariffs by end-Q1FY26, with a conservative expectation of at least Rs. 70-72 per million metric British thermal units (mmbtu) being approved by the...

Praj Industries Ltd. is a leading biotechnology and engineering firm offering sustainable solutions in bioenergy, water & wastewater treatment, brewery technologies, and high-purity systems for the pharma and biotech sectors. With a global presence in over 100 countries, and four manufacturing...

LIC's financial results were healthy, buoyed by strong VNB and AUM, and further supported by robust policy sales (selling 588,107 policies in 24 hours on January 20, 2025, a Guinness World Record). The non-par business has grown significantly, with a 50.3% YoY increase in non-par APE, and now accounts for 27.7% of individual APE. Additionally, the company has been working on improving persistency through decisions such as increasing ticket size, and changing premium and commission...

PPFL is maintaining elevated inventory levels to strategically capture market opportunities, complemented by increased distributor incentives now set at 3%. However, a spillover in inventory loss is expected in Q1FY26 as well. PPFL navigated a challenging FY25, marked by heightened PVC price volatility, channel destocking, and subdued demand due to reduced government spending....

With a pickup in rural demand and improved crop output, we anticipate early signs of recovery in tractor sales. Additionally, upcoming product launches in both the construction *over or under performance to benchmark index equipment and tractor segments are expected to support overall volume growth. Margins are likely to remain resilient at current levels, driven by easing raw material costs and ongoing cost optimization efforts. However, due to a slower-than-expected ramp-up in exports, the strategic benefits from Kubota's partnership in the agribusiness segment may take longer to materialize, reflecting the challenges in international markets. The near-term...

KIMS demonstrated strong financial performance, with key parameters such as average revenue per occupied bed (ARPOB) and average revenue per patient (ARPP) growing on a YoY basis. A spate of initiatives, expansions and new equipment were launched during the year. The company is confident about its future prospects and expects to benefit from its commitment to quality services and expertise. With new units poised to contribute to the company's performance, KIMS...

In FY25, Indigo reported a 17% YoY increase in revenue, primarily driven by an 11% YoY rise in passenger volumes. EBITDA grew by 11% YoY, though it was impacted by a higher forex loss on account of INR depreciation, an increase in lease expenses, costs associated with grounded aircraft (AOG) and elevated airport fees. Added 67 aircraft during the year, taking the total fleet count to 434. Management has guided for a double-digit capacity growth in FY26. The growth outlook remains strong, supported by a robust domestic network and increasing penetration in international markets. Consequently, we are revising our EPS estimates upward by 13.1% for FY26...

JSW Steel's outlook for FY26 remains positive, driven by expected strong demand growth of 8-10% in the Indian market. The company anticipates that its volume ramp-up would meet the increased demand, resulting in lower conversion costs compared to existing operations. Additionally, the focus on renewable energy and the expansion of large and efficient blast furnaces are expected to enhance the company's cost competitiveness. Coking coal costs are expected to decrease in Q1FY26. Overall, EBITDA is expected to improve due to better performance in US...

We expect competition intensity is likely to persist in the short term, however, the demand scenario may pick up due to better forecasts on monsoon and moderation in inflation, which may drive the decorative demand....